{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:04:13Z","timestamp":1791198253579,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003132","name":"IWT","doi-asserted-by":"publisher","award":["SBO\/80020"],"award-info":[{"award-number":["SBO\/80020"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","award":["0768.10"],"award-info":[{"award-number":["0768.10"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["IOF-KP\/07\/001"],"award-info":[{"award-number":["IOF-KP\/07\/001"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["OT\/08\/052A"],"award-info":[{"award-number":["OT\/08\/052A"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["IMIR PF\/10\/017"],"award-info":[{"award-number":["IMIR PF\/10\/017"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MJFox Foundation"}],"content-domain":{"domain":["clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.neurobiolaging.2015.01.014","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T23:17:52Z","timestamp":1421882272000},"page":"1559-1568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an \u03b1-synuclein-based rat model for Parkinson's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Anke","family":"Van der Perren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaan","family":"Toelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne S.","family":"Carlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"de Loor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.J.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Gijsbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Van den Haute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeger","family":"Debyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Baekelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/10430340252899019","article-title":"Characterization of lentiviral vector-mediated gene transfer in adult mouse brain","volume":"13","author":"Baekelandt","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/clpt.2012.109","article-title":"In\u00a0vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients","volume":"92","author":"de Jonge","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib4","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M110.182303","article-title":"Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation","volume":"286","author":"Deleersnijder","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ymthe.2006.05.007","article-title":"Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging","volume":"14","author":"Deroose","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1471-4159.2008.05342.x","article-title":"FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T","volume":"106","author":"Gerard","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib8","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1523\/JNEUROSCI.5983-09.2010","article-title":"Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology","volume":"30","author":"Gerard","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1471-4892(01)00125-4","article-title":"Neuroimmunophilin ligands in the treatment of Parkinson's disease","volume":"2","author":"Gold","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2133\/dmpk.22.328","article-title":"Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics","volume":"22","author":"Iwasaki","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/01.tp.0000241077.83511.be","article-title":"Controlling the generation and function of human CD8+ memory T cells in\u00a0vitro with immunosuppressants","volume":"82","author":"Jones","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1582-4934.2004.tb00259.x","article-title":"Molecular mechanisms of neuroprotective action of immunosuppressants\u2013facts and hypotheses","volume":"8","author":"Kaminska","year":"2004","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-5728(94)90049-3","article-title":"Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL\/6 mice","volume":"50","author":"Kitamura","year":"1994","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib14","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/bi00131a002","article-title":"Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity","volume":"31","author":"Liu","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-510X(97)00100-7","article-title":"Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts","volume":"151","author":"Ma","year":"1997","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib17","doi-asserted-by":"crossref","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","article-title":"Inflammation and adaptive immunity in Parkinson's disease","volume":"2","author":"Mosley","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.clinbiochem.2010.03.016","article-title":"Multi-center evaluation of a commercial kit for tacrolimus determination by LC\/MS\/MS","volume":"43","author":"Napoli","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2004.06.016","article-title":"Neuroimmunophilins: a novel drug\u00a0therapy for the reversal of neurodegenerative disease?","volume":"128","author":"Poulter","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib20","doi-asserted-by":"crossref","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuroscience.2004.08.050","article-title":"Design-based stereology in neuroscience","volume":"130","author":"Schmitz","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12640-009-9053-x","article-title":"Mutant alpha-synuclein overexpression mediates early proinflammatory activity","volume":"16","author":"Su","year":"2009","journal-title":"Neurotox Res."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib23","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson's disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/gt.2010.179","article-title":"Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2\/1, 2\/2, 2\/5, 2\/6.2, 2\/7, 2\/8 and 2\/9","volume":"18","author":"Van der Perren","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib26","doi-asserted-by":"crossref","unstructured":"Van der Perren, A., Toelen, J., Casteels, C., Macchi, F., Van Rompuy, A.S., Sarre, S., Casadei N., Nuber S., Himmelreich U., Osorio Garcia M.I., Michotte Y., D'Hooge R., Bormans G., Van Laere K., Gijsbers R., Van den Haute C., Debyser Z. and Baekelandt V., 2014. Longitudinal characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with rAAV2\/7 viral vectors. Neurobiol. Aging 36, 1543\u20131558.","DOI":"10.1016\/j.neurobiolaging.2014.11.015"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brainres.2008.04.020","article-title":"Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression","volume":"1216","author":"Wright","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib28","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1023\/A:1018993312773","article-title":"P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice","volume":"16","author":"Yokogawa","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/ibd.21318","article-title":"Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis","volume":"16","author":"Yoshino","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.01.014_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/glia.20092","article-title":"A\u00a0novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells","volume":"49","author":"Zawadzka","year":"2005","journal-title":"Glia"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:59:47Z","timestamp":1537923587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0197458015000470"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.01.014","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an \u03b1-synuclein-based rat model for Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}